116 related articles for article (PubMed ID: 2751314)
1. [Analysis of DNA aneuploidy as a tumor marker].
Takamoto S
Gan To Kagaku Ryoho; 1989 Jul; 16(7):2329-37. PubMed ID: 2751314
[TBL] [Abstract][Full Text] [Related]
2. [Analysis of DNA aneuploidy as a tumor marker].
Takamoto S; Kato H
Rinsho Ketsueki; 1990 Jun; 31(6):729-35. PubMed ID: 2214164
[TBL] [Abstract][Full Text] [Related]
3. [A prognostic factor in childhood acute lymphoblastic leukemia: implication of cellular DNA contents. Children's Cancer and Leukemia Study Group].
Katano N; Tsurusawa M; Kawai S; Fujimoto T
Rinsho Ketsueki; 1989 Jul; 30(7):943-50. PubMed ID: 2810797
[TBL] [Abstract][Full Text] [Related]
4. DNA aneuploidy in acute myeloblastic leukemia is associated with a high expression of lymphoid markers.
Vidriales MB; Orfao A; López-Berges MC; González M; López-Macedo A; Ciudad J; López A; Cañizo MC; Garcia MA; San Miguel JF
Cytometry; 1995 Mar; 22(1):22-5. PubMed ID: 7587729
[TBL] [Abstract][Full Text] [Related]
5. PRAME mRNA levels in cases with acute leukemia: clinical importance and future prospects.
Paydas S; Tanriverdi K; Yavuz S; Disel U; Baslamisli F; Burgut R
Am J Hematol; 2005 Aug; 79(4):257-61. PubMed ID: 16044453
[TBL] [Abstract][Full Text] [Related]
6. Significance of FCM-DNA measurement in detecting minimal residual disease in leukemia.
Zhang RX; Yao EG
Chin Med J (Engl); 1990 Oct; 103(10):826-30. PubMed ID: 2125256
[TBL] [Abstract][Full Text] [Related]
7. The importance of blast cell DNA content for prognosis of childhood acute lymphoblastic leukemia.
Starý J; Hrodek O; Hausner P; Petráková A; Goetz P; Kreuger A
Neoplasma; 1990; 37(3):293-9. PubMed ID: 2370916
[TBL] [Abstract][Full Text] [Related]
8. Leukemia-associated phenotypes: their characteristics and incidence in acute leukemia.
Babusíková O; Glasová M; Koníková E; Kusenda J
Neoplasma; 1996; 43(6):367-72. PubMed ID: 8996560
[TBL] [Abstract][Full Text] [Related]
9. Immunological classification of chronic myeloid leukemia distinguishes chronic phase, imminent blastic transformation, and acute lymphoblastic leukemia.
Schmetzer HM; Gerhartz HH
Exp Hematol; 1997 Jun; 25(6):502-8. PubMed ID: 9197328
[TBL] [Abstract][Full Text] [Related]
10. [Prognostic value of the changes in the DNA of blast cells from patients with acute lymphoblastic leukemia].
Conde E; Cuadrado MA; Carretero F; Richard C; Iriondo A; Bureo E; Recio M; Tugues D; Muruzábal MJ; Pérez M
Sangre (Barc); 1989 Apr; 34(2):99-106. PubMed ID: 2756457
[TBL] [Abstract][Full Text] [Related]
11. P53 protein expression in human leukemia and lymphoma cells.
Koníková E; Kusenda J
Neoplasma; 2001; 48(4):290-8. PubMed ID: 11712681
[TBL] [Abstract][Full Text] [Related]
12. [Immunophenotyping of acute leukemias: diagnostic and pronostic utility in Abidjan, Côte d'Ivoire].
Inwoley KA; Sawadogo D; Mizero L; Salou M; Karim N; Sangaré A
Bull Soc Pathol Exot; 2004; 97(5):319-22. PubMed ID: 15787262
[TBL] [Abstract][Full Text] [Related]
13. Predictors for prognosis of chronic myelocytic leukemia.
Chen SS; Zhang HF; Xue WT; Li K; Wang P; Lui Y
Chin Med J (Engl); 1993 Oct; 106(10):760-2. PubMed ID: 7913433
[TBL] [Abstract][Full Text] [Related]
14. [Evaluation of cell cycle in acute leukemias and non-Hodgkin's lymphomas in children].
Pituch-Noworolska A; Gawlicka M
Acta Haematol Pol; 1993; 24(4):365-71. PubMed ID: 8303983
[TBL] [Abstract][Full Text] [Related]
15. [Flow cytometry in the determination of DNA aneuploidy in patients with acute leukemias].
Shmarov DA; Kuchma IuM; Miterev GIu; Kozinets GI
Ter Arkh; 1996; 68(7):11-4. PubMed ID: 8928064
[TBL] [Abstract][Full Text] [Related]
16. Leukemia markers expression of peripheral blood vs bone marrow blasts using flow cytometry.
Rezaei A; Adib M; Mokarian F; Tebianian M; Nassiri R
Med Sci Monit; 2003 Aug; 9(8):CR359-62. PubMed ID: 12942032
[TBL] [Abstract][Full Text] [Related]
17. Comparison of mRNA abundance quantified by gene expression profiling and percentage of positive cells using immunophenotyping for diagnostic antigens in acute and chronic leukemias.
Kern W; Kohlmann A; Schoch C; Schnittger S; Haferlach T
Cancer; 2006 Nov; 107(10):2401-7. PubMed ID: 17041886
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of BCL-2 oncoprotein and Fas antigen on normal peripheral blood and leukemic bone marrow cells. A flow cytometric analysis.
Molica S; Mannella A; Dattilo A; Levato D; Iuliano F; Peta A; Consarino C; Magro S
Haematologica; 1996; 81(4):302-9. PubMed ID: 8870373
[TBL] [Abstract][Full Text] [Related]
19. Aneuploidy as a marker of minimal residual disease in leukemia.
Walle AJ; Niedermayer W
Cancer Detect Prev; 1985; 8(1-2):303-15. PubMed ID: 4064049
[TBL] [Abstract][Full Text] [Related]
20. [Clinical significance of CD117/CD34 co-expression in adult patients with acute leukemia].
Shi H; Zhu F; Xiao AQ; Zhang ZR; Zhang R
Ai Zheng; 2006 Jun; 25(6):762-4. PubMed ID: 16764777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
